CIB Earnings

CIB reported its earnings on 2026-02-23, showcasing a revenue of 1.27B against an estimate of 7.15B, resulting in a -82.25% surprise. The EPS was -2.05, surpassing the expected 2.04 by -200.49%. The stock experienced a -5.87% price change on the earnings day and a -15.62% change over the next five days, reflecting market reactions to the results.

Following CIB's earnings announcement on 2026-02-23, the stock price moved by -5.87% on the day of the release. Over the subsequent five days, it saw a -15.62% change. Historically, CIB's stock price tends to shift by an average of -0.09% in the 10 days leading up to earnings and -0.38% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate CIB's annual revenue to reach 7.70T, while the EPS is projected at 1.98. These estimates reflect recent revisions, with revenue estimates revised upward by 2.29% and EPS estimates revised upward by 0.28% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CIB's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 2.29%, while EPS estimates moved revised upward by 0.28%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CIB's stock price typically moves by -0.09% in the 10 days before its earnings and -0.38% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 1.98 and revenue of 7.70T.

The earnings call summary indicates strong financial performance with a significant reduction in net provisions and improved asset quality. Nequi's digital growth is impressive, and the company plans strategic investments in technology and digital ventures. The Q&A section reveals confidence in managing risks and a commitment to shareholder returns through a buyback program. Despite macroeconomic challenges, the guidance remains optimistic, with a projected ROE of 17%-18%. Overall, the sentiment is positive, likely leading to a stock price increase of 2% to 8% over the next two weeks.